Evidence map›Paper›PMID 33912721›Full record

ArticleHeliyon2021

Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis.

Kássya Mycaela Paulino Silva, Francisco Lucas de Sousa, Ana Carolina Barreto Alves, Pollyana Alves Rocha, Hildegard Naara Alves Furtado da Costa, Waldilene Rodrigues Ferreira, Taianara Sampaio Reis, Tharcia Kiara Beserra de Oliveira, Sandra Rejane Cabral Batista, Clovis José Cavalcanti Lapa Neto and 2 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Review
  4. The Current Role of Disease-modifying Osteoarthritis Drugs.The archives of bone and joint surgery · 2023
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kássya Mycaela Paulino SilvaFederal University of Campina Grande (UFCG), Department of Medicine (UAMED), Campina Grande, PB, Brazil.
Francisco Lucas de SousaUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Ana Carolina Barreto AlvesUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Pollyana Alves RochaUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Hildegard Naara Alves Furtado da CostaUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Waldilene Rodrigues FerreiraUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Taianara Sampaio ReisUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Tharcia Kiara Beserra de OliveiraUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Sandra Rejane Cabral BatistaUNIFACISA University, School of Medicine (FCM), Campina Grande, PB, Brazil.
Clovis José Cavalcanti Lapa NetoRural Federal University of Pernambuco (UFRPE), Animal Morphology and Physiology Department, Recife, PE, Brazil.
Anne Gabrielle OliveiraNortheastern Strategic Technologies Center (CETENE), Recife, PE, Brazil.
Ana Janaina Jeanine M de Lemos JordãoFederal University of Campina Grande (UFCG), Department of Medicine (UAMED), Campina Grande, PB, Brazil.
Universidade Federal de Campina Grande · BRCentro de Tecnologias Estratégicas do Nordeste · BRUniversidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyze the action of strontium ranelate (SR) and melatonin in isolation or in association in knees, liver and kidneys of rats Wistar with induced osteoarthritis (OA).

methodsThirty male rats were induced to OA through an anterior cruciate ligament transection (ACLT), and treated with melatonin and SR in isolation or in association. Morphological, histopathological, histochemical and morphometric analysis were realized of the structure of the articular capsule, as well as histopathological analysis of liver and kidneys from the animals.

resultsThe experimental model was successful. The association of the drugs presented chondroprotective pharmacodynamics. However, more successful results were identified from analysis of animals in which received melatonin in isolation, regarding biochemical parameters of glutamic oxalacetic transaminase. The prepared slide samples of liver and kidneys from groups submitted to the isolated use of SR and melatonin or the association of these drugs presented no differences, when compared to the control group. DISCUSSION: The administration of the drugs presented chondroprotective effect and prevented from the aggravation of articulate damages, and was not capable of modifying the histology of liver or kidneys. This finding suggests a safe association for the treatment of OA, however it requires further investigation in order to expand therapeutic perspectives regarding improvements of the quality of life of individuals in our society.

Indexed as

MelatoninOsteoarthritisStrontium ranelate

Identifiers

PMID33912721
PMCPMC8066349
OpenAlexW3154117670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.